These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34738551)

  • 1. Nicorandil Decreases Renal Injury in Patients With Coronary Heart Disease Complicated With Type I Cardiorenal Syndrome.
    Du X; Ma Z; Li L; Zhong X
    J Cardiovasc Pharmacol; 2021 Sep; 78(5):e675-e680. PubMed ID: 34738551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating miRNA-21 as a diagnostic biomarker in elderly patients with type 2 cardiorenal syndrome.
    Wang Y; Liang Y; Zhao W; Fu G; Li Q; Min X; Guo Y
    Sci Rep; 2020 Mar; 10(1):4894. PubMed ID: 32184430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qiliqiangxin Protects against Renal Injury in Rat with Cardiorenal Syndrome Type I through Regulating the Inflammatory and Oxidative Stress Signaling.
    Duan X; Yan F; Hu H; Liu H; Wu Q; Sun S; Ming X; Bu X; He Y; Zhu H
    Biol Pharm Bull; 2018; 41(8):1178-1185. PubMed ID: 30068867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
    Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
    Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney injury molecule-1 and N-acetyl-β-D-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome.
    Jungbauer CG; Birner C; Jung B; Buchner S; Lubnow M; von Bary C; Endemann D; Banas B; Mack M; Böger CA; Riegger G; Luchner A
    Eur J Heart Fail; 2011 Oct; 13(10):1104-10. PubMed ID: 21846754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
    Palazzuoli A; Ruocco G; Pellegrini M; De Gori C; Del Castillo G; Franci B; Nuti R; Ronco C
    Am J Cardiol; 2015 Jul; 116(1):104-11. PubMed ID: 25943992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary Biomarkers at the Time of AKI Diagnosis as Predictors of Progression of AKI among Patients with Acute Cardiorenal Syndrome.
    Chen C; Yang X; Lei Y; Zha Y; Liu H; Ma C; Tian J; Chen P; Yang T; Hou FF
    Clin J Am Soc Nephrol; 2016 Sep; 11(9):1536-1544. PubMed ID: 27538426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiorenal syndrome: the role of new biochemical markers].
    Vernuccio F; Grutta G; Ferrara F; Novo G; Novo S
    Recenti Prog Med; 2012 Dec; 103(12):559-63. PubMed ID: 23258238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of Serum Creatinine and Kidney Injury Biomarkers for Diagnosing Histologic Acute Tubular Injury.
    Moledina DG; Hall IE; Thiessen-Philbrook H; Reese PP; Weng FL; Schröppel B; Doshi MD; Wilson FP; Coca SG; Parikh CR
    Am J Kidney Dis; 2017 Dec; 70(6):807-816. PubMed ID: 28844586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are there any new reliable markers to detect renal injury in obese children?
    Bostan Gayret Ö; Taşdemir M; Erol M; Tekin Nacaroğlu H; Zengi O; Yiğit Ö
    Ren Fail; 2018 Nov; 40(1):416-422. PubMed ID: 30035656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of Proinflammatory Cytokines, Oxidative Stress, and Tissue Damage Markers in Patients with Acute Heart Failure with and without Cardiorenal Syndrome Type 1.
    Virzì GM; Breglia A; Brocca A; de Cal M; Bolin C; Vescovo G; Ronco C
    Cardiorenal Med; 2018; 8(4):321-331. PubMed ID: 30205401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiorenal status using amino-terminal pro-brain natriuretic peptide and cystatin C on cardiac resynchronization therapy outcomes: From the BIOCRT Study.
    Truong QA; Szymonifka J; Januzzi JL; Contractor JH; Deaño RC; Chatterjee NA; Singh JP
    Heart Rhythm; 2019 Jun; 16(6):928-935. PubMed ID: 30590191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of kidney function in diabetic patients. Is there a role for new biomarkers NGAL, cystatin C and KIM-1?
    Matys U; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S
    Adv Med Sci; 2013; 58(2):353-61. PubMed ID: 24384771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure.
    Palazzuoli A; Ruocco G; Beltrami M; Franci B; Pellegrini M; Lucani B; Nuti R; Ronco C
    Acute Card Care; 2014 Sep; 16(3):93-101. PubMed ID: 24836558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine KIM-1 as a Potential Biomarker of Acute Renal Injury After Circulatory Collapse in Children.
    Assadi F; Sharbaf FG
    Pediatr Emerg Care; 2019 Feb; 35(2):104-107. PubMed ID: 27741065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil gelatinase-associated lipocalin curve and neutrophil gelatinase-associated lipocalin extended-range assay: a new biomarker approach in the early diagnosis of acute kidney injury and cardio-renal syndrome.
    Ronco C; Cruz D; Noland BW
    Semin Nephrol; 2012 Jan; 32(1):121-8. PubMed ID: 22365170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Renal Stress/Damage and Filtration Biomarkers with Subsequent AKI during Hospitalization among Patients Presenting to the Emergency Department.
    Kimmel M; Shi J; Latus J; Wasser C; Kitterer D; Braun N; Alscher MD
    Clin J Am Soc Nephrol; 2016 Jun; 11(6):938-946. PubMed ID: 27026519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical therapeutic strategy of recombinant human brain natriuretic peptide and dopamine in cardiorenal syndrome type 4 patients combined with hypotension.
    Han B; Li H; Ma Q
    Pak J Pharm Sci; 2017 Jul; 30(4(Suppl.)):1449-1453. PubMed ID: 29043996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Novel Biomarkers of Acute Kidney Injury: The Possibilities and Limitations.
    Medić B; Rovcanin B; Vujovic KS; Obradovic D; Duric D; Prostran M
    Curr Med Chem; 2016; 23(19):1981-97. PubMed ID: 26860999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers for acute cardiorenal syndrome.
    Fan PC; Chang CH; Chen YC
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():68-71. PubMed ID: 30298648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.